Related references
Note: Only part of the references are listed.Treatment With Liraglutide-a Once-Daily GLP-1 Analog-Does Not Reduce the Bioavailability of Ethinyl Estradiol/Levonorgestrel Taken as an Oral Combination Contraceptive Drug
Lisbeth V. Jacobsen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
Julio Rosenstock et al.
DRUGS OF THE FUTURE (2010)
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes A randomized controlled trial exploring weekly, biweekly, and monthly dosing
Julio Rosenstock et al.
DIABETES CARE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes
Jessica E. Matthews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men
Danny Soon et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Effect of exenatide on the steady-state pharmacokinetics of digoxin
PA Kothare et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
SH Saydah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Evaluation of risk factors for development of complications in Type II diabetes in Europe
A Liebl et al.
DIABETOLOGIA (2002)
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh et al.
CHEST (2001)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
